Skip navigation

Calls to Action

Translational

September 13, 2014

(NEW HAVEN, CT.) September 13, 2014 -  The New England Chapter of Autism Speaks, together with the the Center for Translational Developmental Neuroscience at Yale, hosted an autism science conference. The meeting brought together scientists, parents, adults with autism and professionals who work with people with autism for a day of learning about autism science. 

Janssen R&D taps Autism Speaks expertise to develop award-winning platform for optimizing development of autism medicines and care
February 24, 2014

This weekend, the Microsoft Health Users Group (Microsoft HUG) awarded Janssen Research & Development its Innovation Award for the company’s Autism Knowledge Engine. Autism Speaks provided scientific guidance in developing the platform.

Research investments in wandering prevention, treatment safety, early access to care and environmental influences on autism risk
January 06, 2014

Autism Speaks is pleased to announce new funding for thirteen research projects that will run over the next three years, for a total investment of $2,696,703 to advance understanding and treatment of autism and its related medical conditions.

Oxytocin appears to partner with another vital brain chemical – serotonin – to make social contact rewarding
September 13, 2013

Stanford University researchers have shown that the so-called “love” hormone oxytocin is involved in a broader range of social interactions than previously thought.

Their new report in the journal Nature urges researchers to use the findings to open new doors in the search for autism treatments.

Postdoctoral Fellowships Program Renamed Meixner Translational Postdoctoral Fellowships in Honor of Charles Meixner’s Legacy

Autism Speaks announced the estate of Charles Meixner donated $3 million to support Autism Speaks’ Translational Research Initiative

August 07, 2013

NEW YORK, N.Y. (August 7, 2013) – Autism Speaks, the world’s leading autism science and advocacy organization, today announced that the estate of Charles Meixner has donated $3 million to support Autism Speaks’ Translational Research Initiative in the hopes of accelerating the discovery of treatments for autism spectrum disorder (ASD). An initial distribution of $1.75 million from the gift will fund Autism Speaks’ translational postdoctoral fellowships, which invests in rising talent within the autism research community.

DELSIA, an independent not-for-profit affiliate of Autism Speaks, will focus on accelerating the translation of scientific breakthroughs into products that will improve quality of life and health for those affected by autism

Autism Speaks announced the formation of Delivering Scientific Innovation for Autism (DELSIA) an independent not-for-profit affiliate o

October 25, 2012

NEW YORK, N.Y. (October 25, 2012) – Autism Speaks, the world’s leading autism science and advocacy organization, today announced the formation of Delivering Scientific Innovation for Autism (DELSIA) an independent not-for-profit affiliate of Autism Speaks that will work directly with for-profit sector partners to stimulate the conversion of scientific research from the lab into products needed by both the autism and medical communities, more rapidly and effectively.